MANAGEMENT OF ADVANCED ESOPHAGEAL CARCINOMA POTENTIALLY INFILTRATING TO THE ADJACENT ORGANS:USEFULNESS OF PREOPERATIVE CONCURRENT CHEMO-RADIATION THERAPY

概要

論文の詳細を見る
A retrospective analysis was conducted to evaluate the prognostic benefit of various treatments for advanced esophageal carcinoma potentially infiltrating to the adjacent organs. In 77 enrolled patients, primary resection (11 cases, median survival time, MST: 281 days) and concurrent chemo (5FU CDDP)-radiation (FPRT) (23 cases, MST: 238 days) had prognostic advantages in comparison with palliative treatment (11 cases, MST: 94 days), but radiation therapy with daily rectal futraful administration (5 FURT) had no benefit (11 cases, MST: 169 days). In the primary resected cases, sufficient postoperative adjuvant therapies were feasible in 52%, and local and/or nodal recurrence was found in 61%. In FPRT cases, the local response rate was 79%, whereas the general response rate was 66% due to the association of distant metastasis in 5 cases. The resection rate after FPRT was 52%. Operative curability was superior in cases preceded by FPRT to those undergoing primary resection, and two year survival rates were 33% and 12%, respectively. FPRT is useful as a neoadjuvant therapy and subsequent curative resection may increase the chance for a long-term survival.
日本臨床外科学会の論文